Disease Diagnosis TRIZ Cases

CXCL14 blood concentration trends predict transplant need, avoiding unnecessary surgery risks in acetaminophen hepatotoxicity cases.

Extracting GAPDH as a single biomarker via ELISA simplifies testing procedures while maintaining high diagnostic accuracy and specificity.

A humanized anti-DKK2 antibody neutralizes Dickkopf2 protein to enhance CD8+ cytotoxic T lymphocyte activity within the tumor microenvironment.

Specific antibodies detect 5-fluorouracil in plasma samples to resolve toxicity risks from metabolic variability.

Segmenting patients by HPV status via p16 INK4A testing resolves the contradiction between broad EGFr inhibitor applicability and specific treatment efficacy.

Detecting antibodies against carbamylated β2-glycoprotein I identifies seronegative antiphospholipid syndrome cases missed by standard tests.

An immunoassay detects pro-neurotensin levels in bodily fluids to assess fat processing activity.

A lipHsp70 sandwich ELISA uses the cmHsp70.1 monoclonal antibody to detect inducible Hsp70 levels in body fluids.

Segmented assays using synthetic fibril templates detect amyloidogenic proteins by signal intensity, resolving accuracy versus complexity trade-offs.

Combine biochemical biomarker analysis with biomechanical evaluation to predict joint injury risk before occurrence.

Measuring urinary podocalyxin concentrations resolves timing delays in serum creatinine diagnostics by providing early cellular damage markers.

Antigen titration curves resolve false results from individual antibody variations by mapping binding responses.

A multiplexed immunoassay measures IL-15, CD5, Flt-3L, and salivary amylase concentrations in biological samples to determine radiation exposure levels.

Measuring CD24 levels on small leukocytes via flow cytometry enables non-invasive early cancer detection without invasive biopsies.

MALDI-TOF mass spectrometry identifies unique peptide patterns in serum to diagnose arthrosis before radiological changes appear.

Plasma osteopontin levels diagnose traumatic brain injury in pediatric subjects.

Zebrafish xenograft models analyze tumor innate immune interactions to identify biomarkers and immunomodulators.

A sandwich immunoassay uses two monoclonal antibodies to detect ProGRP tumor markers with high sensitivity.

Membrane STIM1 protein fraction serves as a specific biomarker for detecting chronic lymphoid leukaemia and systemic lupus erythematosus.

Quantifying tumor-associated carbohydrate Ca10 levels enables in vitro cancer detection while addressing tumor escape mechanisms that induce regulatory T cells.

Segmenting diagnostic processes via multi-parameter biomarker panels distinguishes sepsis from non-septic SIRS, enabling early acute kidney injury detection.

Procalcitonin measurement identifies bacterial infections in patients with non-specific complaints using tiered concentration thresholds.

Segmentation of specific antibody and mast cell measurements resolves the contradiction between diagnostic accuracy and method complexity.

Direct RANKL administration bypasses slow indirect pathways, enabling rapid osteopenia model development for efficient drug evaluation.

Analyze individual neutrophils from whole blood to monitor brain health states, bypassing traditional PBMC exclusions that limit biomarker coverage.

Segmenting specific protein molecules into measurable fragments enables early detection of diabetic nephropathy before microalbuminuria develops.

Measuring PD-ECGF protein levels via immunohistochemistry or ELISA improves diagnostic precision and treatment prediction reliability for renal cell carcinoma.

Detect Ambra-1 and p62 expression levels in tissue samples to identify squamous cell carcinoma progression risk.

Site-directed mutagenesis of Aleuria aurantia lectin restores binding sites blocked by covalently bound fucose, improving detection sensitivity.

Leukocytes bound to fluorescent-staining inhibitors mimic human nucleated red blood cell optical properties.

A method measures 13-series resolvin levels in biological samples to assess statin efficacy.

Sulfurous acid compounds suppress hemoglobin denaturation during electrophoresis, preventing oxidation errors.

Hepatocyte growth factor levels indicate adverse events, enabling timely treatment modification despite poor prognosis from standard therapies.

A computer system analyzes urine specific gravity, creatinine, and blood urea nitrogen to determine feline susceptibility to chronic kidney disease.

Urinary human megalin quantifies renal tubular dysfunction via ligand-receptor binding, bypassing serum creatinine limitations.

Measuring CT-proET-1 via sandwich immunoassay predicts tachyarrhythmia risk, preventing inappropriate ICD implantation and adverse effects.

Lateral flow test strips detect HDL-P and LDL-P concentrations using antibody-coated particles, replacing cholesterol metrics with direct particle counts.

Engineered mucin-specific proteases cleave glycan-peptide motifs to release glycosylated fragments.

Measuring anti-inflammatory cytokines IL-1ra and TNFsr2 enables early identification of at-risk patients before significant renal damage occurs.

Quantifying specific immune cell subtypes enables early prediction of treatment efficacy and disease reactivation in multiple sclerosis patients.

Image analysis of earthworm movement quantifies ocular discomfort, replacing lengthy in vitro culture methods with a faster, cost-effective testing approach.

Administering caspase 4 inhibitors reduces inflammation and thrombosis in coronavirus infections.

A plasma biomarker panel detects peripartum cardiomyopathy by measuring angiogenic factors, replacing complex echocardiography with accessible blood testing.

IGFBP7 biomarker measurement enables accurate diagnosis of diastolic dysfunction in heart failure patients.

Extraction of endothelial cell-derived exosomes isolates specific biomarkers to improve detection accuracy and diagnostic reliability for vascular diseases.

A method adjusts urinary C-peptide excretion rates against average glucose concentrations to assess insulin sensitivity.

Skin fibroblast networks replicate brain pathology to diagnose Alzheimer's disease without invasive procedures.

Immunofluorescence detects HER2 protein expression in tumor tissue samples for personalized breast cancer therapy selection.

Combining multiple BARD1 protein segments increases sensitivity for early-stage lung cancer detection without invasive tissue sampling.

A diagnostic method quantifies cellular LDL uptake and receptor expression to identify subjects likely to respond to lipid lowering therapy.